COVID- 19 Vaccine – Sputnik
- In December 2019, a completely unique coronavirus called SARS-CoV-2 has resulted within the outbreak of a respiratory disorder referred to as COVID-19. Months are passed under lockdown as there’s no Vaccine or Cure for this Virus.
- Now we got an excellent relief that the primary batch of Russia’s Sputnik V vaccine for COVID-19 has arrived in India following the nod to Hyderabad-based pharma, Dr. Reddy’s Laboratories to conduct an adaptive phase 2/3 human trial for the Vaccine in India. The human test of Vaccine 2 and Vaccine 3 are yet to be conducted in India to grasp the protection and efficacy of the virus.
About Sputnik – V:
Sputnik V is that the world’s first registered vaccine supported a well-studied human adenoviral vector-based platform. It currently ranks among top-10 candidate vaccines approaching the top of clinical trials and also the start of production on the globe Health Organization’s (WHO) list.
Sputnik – V Vaccine is developed by Russia’s Gamleya National Research Institute of Epidemiology and Microbiology. The Sputnik V covid vaccine has got to be kept at a temperature of -20 to -70 degrees Celsius.
- On August 2020, the Sputnik V Vaccine was registered by the Ministry of Health of Russia and have become the world’s first registered vaccine against COVID- 19 supported the human adenoviral vectors platform.
- On September 2020- Vaccine was first administered to a bunch of volunteers from the red zones of Russian Hospitals.
- Developers of Sputnik V, RIDF and Gamaleya Institute announced that the interim data from an oversized trial suggests the shot appears to be 95% effective.
One does of Sputnik- V contains two shots which is to be given nearly a month apart.
- The first shot consists of a genetically modified and weakened human ‘adenovirus’, or communicable disease virus, which is able to be accustomed carry the code for the cells within the body to form the spike protein–the spiky outer layer of the SARS-CoV-2 virus that causes Covid-19.
- The second shot performs this function employing a different genetically modified and weakened human adenovirus.
As a part of the clinical trials in Russias 29 medical centres, quite 20,000 volunteers were vaccinated with the primary dose and over 16,000 volunteers with the first and therefore the second dose of the vaccine.In addition, as on the date, no unexpected adverse events were identified as a part of the research.
Download COVID- 19 Vaccine – Sputnik PDF
- Last 6 Months Current Affairs PDFs
- Click here to get Daily Current Affairs
- Click here to get Daily Current Affairs Quiz
